Japan Advances iPS Cell Technology with New Osaka Facility

Mar 20, 2025 | News On Japan

OSAKA - A new facility for the research and production of induced pluripotent stem (iPS) cells has been completed in Osaka's Nakanoshima district and was unveiled to the press on March 19th.

Named "Yanai My iPS," the facility was established with a donation from Tadashi Yanai, CEO of Fast Retailing, the company behind Uniqlo and GU. iPS cells, which can transform into various types of cells, are seen as key to regenerative medicine. Currently, they are primarily derived from donor cells, which carries the risk of immune rejection. However, using a patient’s own cells could significantly reduce this risk.

The facility is focusing on developing technology for autologous iPS cells, which are created from a patient’s own tissues. Traditionally, producing iPS cells required manual labor, pushing costs into the tens of millions of yen. However, the new facility aims to provide autologous iPS cells to research institutions for about 1 million yen by the end of this year. The ultimate goal is to begin clinical trials for human treatment by 2028.

iPS cells are reprogrammed from adult cells, such as skin or blood cells, into a pluripotent state, allowing them to transform into almost any cell type. This breakthrough has opened new possibilities for regenerative medicine, offering potential treatments for diseases such as Parkinson’s and macular degeneration while avoiding the ethical concerns associated with embryonic stem cells.

Japan’s government has invested heavily in iPS cell research through institutions like the Center for iPS Cell Research and Application (CiRA) at Kyoto University, led by Yamanaka. Public and private sectors have collaborated to accelerate clinical applications, with several groundbreaking trials already conducted. In 2014, Japan carried out the world’s first iPS cell transplant for macular degeneration. In 2020, iPS-derived cells were tested as a treatment for Parkinson’s disease, showing early promise. More recently, researchers have explored using iPS cells to generate lab-grown blood for transfusions and potential therapies for heart and liver conditions.

A major challenge in iPS research has been the high cost of production, with patient-specific iPS cells initially costing tens of millions of yen. Recent efforts aim to reduce costs and develop mass production systems, making iPS treatments more widely accessible. New facilities, such as the recently opened Yanai My iPS center in Osaka, are working to lower production costs and pave the way for clinical use, with human trials expected in the coming years.

Source: Television OSAKA NEWS

Toyota to Launch Self-Driving Taxis in 2027

Toyota Motor will begin operating fully autonomous taxis in 2027 through a partnership with U.S. self-driving technology company Waymo, marking a major step in the Japanese automaker's efforts to expand driverless transportation services.

Mount Fuji Puts on First Snowcap

Mount Fuji has received its first snowcap of the season, the Japan Meteorological Agency announced on October 30, after temperatures at the summit plunged to minus 9.4 degrees Celsius, marking the arrival of winter conditions on Japan's highest mountain.

Chinese Female Spy Suspected of Targeting Nvidia Chief

U.S. intelligence agencies suspect that a Chinese female intelligence operative developed a close relationship with Nvidia CEO Jensen Huang in an attempt to obtain confidential corporate and U.S. government information, according to a report published by The New York Times on October 29th.

Japan Blocks Websites Leaking GMO Personal Data

The Japanese government has asked major telecommunications operators to forcibly block access to websites believed to contain personal information stolen in a cyberattack on GMO, it emerged on October 29th, as authorities moved to prevent further exposure of sensitive data online.

Typhoon No. 31 Heads Toward Japan's Remote Islands

Typhoon No. 31 was located near Minamitorishima Island in the Pacific Ocean, as of 3 a.m. on October 30, and was expected to approach the Ogasawara Islands south of Tokyo over the October 31-November 1 weekend while maintaining very strong intensity, bringing a growing risk of dangerously high waves, powerful swells and extremely rough seas.

MEDIA CHANNELS

MORE Sci-Tech NEWS

First Parkinson's Patient Receives iPS Cell Treatment at Kyoto University Hospital

Japanese pharmaceutical company Sumitomo Pharma announced on October 30 that the first patient to receive its newly approved regenerative medicine treatment for Parkinson's disease underwent a successful brain cell transplant at Kyoto University Hospital in early October, with the woman in her 50s already returning to work and recovering well.

How Automated Port Cranes Are Reshaping Japan's Logistics Industry

Japan's ports have long been the backbone of one of the world's most export-driven economies.

New Garbage Station Messes With Crows

A company in Kagoshima has developed a new garbage collection station that uses specially shaped wires and rollers instead of conventional nets to prevent crows from scattering household waste, offering a cleaner and more convenient solution to a persistent problem in Japan's urban neighborhoods.

Why Phobos? Japan Targets Tiny Moon Over Mars

Japan has chosen a small, irregularly shaped moon orbiting Mars rather than the planet itself for its latest space exploration mission, taking advantage of Phobos' extremely weak gravity and lack of atmosphere to make collecting extraterrestrial samples and returning them to Earth far easier and less expensive, while potentially unlocking secrets about the history of Mars and the origins of water and organic materials in the solar system.

H3 Rocket Successfully Launches Mars Moon Probe

Japan's H3 rocket successfully launched the Martian Moons eXploration (MMX) spacecraft from the Tanegashima Space Center in Kagoshima Prefecture on the morning of October 20th, placing the probe into its planned orbit in the first stage of a mission to collect samples from one of Mars' moons and return them to Earth.

JR West Unveils Humanoid Robots

JR West has unveiled multifunctional railway maintenance machinery, including a heavy-duty single-arm robot and a mass-produced humanoid robot, as part of efforts to address labor shortages and reduce workplace accidents in railway maintenance operations.

Subaru Unveils Advanced Driver Assistance System

Subaru unveiled experimental vehicles equipped with a new driver assistance system on October 18, introducing technology that can automatically guide a vehicle to a safe roadside location when the driver becomes incapacitated, with plans to introduce the system in production models by the late 2020s.

H3 Rocket on Mission to Collect Rocks From Mars Moon

Japan will launch its H3 rocket No. 10 from the Tanegashima Space Center in Kagoshima Prefecture at 4:41 a.m. on October 20, carrying a spacecraft designed to collect rocks and sand from Phobos, one of Mars' two moons, and return them to Earth in what would be the world's first successful mission of its kind.

< 2 3 4 5 >